Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
About
BioNTech SE is a German multinational biotechnology company that develops and commercializes innovative immunotherapies and vaccines, particularly for cancer and infectious diseases. Leveraging its expertise in mRNA technology, immunology, and AI, the company aims to translate scientific discoveries into life-saving treatments and usher in a new era of medicine.
Tags
Total Employees
5.1K
Current headcount
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BioNTech do?
BioNTech SE is a German multinational biotechnology company that develops and commercializes innovative immunotherapies and vaccines, particularly for cancer and infectious diseases. Leveraging its expertise in mRNA technology, immunology, and AI, the company aims to translate scientific discoveries into life-saving treatments and usher in a new era of medicine.
How much funding has BioNTech raised?
BioNTech has raised a total of $975M in funding. The most recent round on record is Loan.
Where is BioNTech headquartered?
BioNTech is headquartered in Mainz, Germany.
When was BioNTech founded?
BioNTech was founded in 2008.
What industry does BioNTech operate in?
BioNTech operates in Biotechnology, Drug Discovery, Oncology, Immunotherapy, mRNA Therapeutics, Vaccines.
How many employees does BioNTech have?
BioNTech has approximately 5128 people on record.